Compare OPK & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPK | ECPG |
|---|---|---|
| Founded | 2007 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 998.0M | 905.2M |
| IPO Year | 1995 | 1999 |
| Metric | OPK | ECPG |
|---|---|---|
| Price | $1.37 | $52.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $2.28 | ★ $61.67 |
| AVG Volume (30 Days) | ★ 2.8M | 276.7K |
| Earning Date | 10-29-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $642,067,000.00 | ★ $1,560,869,000.00 |
| Revenue This Year | N/A | $31.88 |
| Revenue Next Year | N/A | $3.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 17.52 |
| 52 Week Low | $1.11 | $26.45 |
| 52 Week High | $2.04 | $53.63 |
| Indicator | OPK | ECPG |
|---|---|---|
| Relative Strength Index (RSI) | 51.24 | 64.28 |
| Support Level | $1.24 | $51.00 |
| Resistance Level | $1.35 | $53.63 |
| Average True Range (ATR) | 0.05 | 1.65 |
| MACD | 0.01 | 0.24 |
| Stochastic Oscillator | 96.15 | 73.13 |
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.